CINPHA — Cinclus Pharma Holding publ AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK817.99m
- SEK338.63m
- SEK57.47m
Annual cashflow statement for Cinclus Pharma Holding publ AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -84.3 | -213 | -201 | -170 | -200 |
| Depreciation | |||||
| Non-Cash Items | 0 | 2.51 | -4.32 | -4.82 | -4.18 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 8.85 | 16.9 | -5.15 | -5.25 | 127 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -75.4 | -192 | -209 | -178 | -74.6 |
| Capital Expenditures | -0.131 | 0 | — | — | -1.13 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | 0 | — | -0.295 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.131 | 0 | 0 | — | -1.43 |
| Financing Cash Flow Items | -0.128 | -15.4 | -0.167 | -58.4 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.95 | 226 | 123 | 655 | -1.76 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -70.3 | 35.3 | -85.6 | 479 | -79.5 |